Journal of Biological Chemistry · 2004 · 150 citations · 27 references
Life SciencesMolecular BiologyOncologyApoptosisMolecular OncologyNeoplasiaApoptosis In CancerApoptosis RegulationApoptosis ResistanceOvarian CancerTelomere Biology In CancerTelomere MaintenanceCancer Cell ApoptosisOvarian ApoptosisReverse Transcription Polymerase Chain Reaction (Rt-pcr)Telomerase EnzymeTelomerase RegulationTelomerase Reverse TranscriptaseTelomere Length RegulationTranscriptional Repression
The maintenance of telomere length is required for continued cell proliferation, and ∼85–90% of human cancers, including ovarian epithelial cancers (OCa), show high activity of telomerase. In the present study we report that 1,25-dihydroxyvitamin D3 (1,25(OH)2 VD)3induces OCa cell apoptosis by down-regulating telomerase. Quantitative reverse transcription-PCR analysis shows that 1,25(OH)2VD3 decreases the level of human telomerase reverse transcriptase (hTERT) mRNA, the catalytic subunit of telomerase. The decrease is not due to transcriptional repression through the putative vitamin D response element present in the 5′ regulatory region of hTERT gene. Instead, 1,25(OH)2 VD3 decreases the stability of the hTERT mRNA. Stable expression of hTERT in OCa cells decreases their response to 1,25(OH)2VD3-induced growth suppression. Although the cell cycle progression of these clones stably expressing hTERT is inhibited by 1,25(OH)2VD3 to a similar degree as that of the parental cells, these clones are more resistant to apoptosis induced by 1,25(OH)2VD3 .In contrast to parental cells, which lose proliferation potential after the 1,25(OH)2VD3 treatment, hTERT-expressing clones resume rapid growth after withdrawal of 1,25(OH)2VD3. Overall, the study suggests that the down-regulation of telomerase activity by 1,25(OH)2VD3 and the resulting cell death are important components of the response of OCa cells to 1,25(OH)2VD3-induced growth suppression. The maintenance of telomere length is required for continued cell proliferation, and ∼85–90% of human cancers, including ovarian epithelial cancers (OCa), show high activity of telomerase. In the present study we report that 1,25-dihydroxyvitamin D3 (1,25(OH)2 VD)3induces OCa cell apoptosis by down-regulating telomerase. Quantitative reverse transcription-PCR analysis shows that 1,25(OH)2VD3 decreases the level of human telomerase reverse transcriptase (hTERT) mRNA, the catalytic subunit of telomerase. The decrease is not due to transcriptional repression through the putative vitamin D response element present in the 5′ regulatory region of hTERT gene. Instead, 1,25(OH)2 VD3 decreases the stability of the hTERT mRNA. Stable expression of hTERT in OCa cells decreases their response to 1,25(OH)2VD3-induced growth suppression. Although the cell cycle progression of these clones stably expressing hTERT is inhibited by 1,25(OH)2VD3 to a similar degree as that of the parental cells, these clones are more resistant to apoptosis induced by 1,25(OH)2VD3 .In contrast to parental cells, which lose proliferation potential after the 1,25(OH)2VD3 treatment, hTERT-expressing clones resume rapid growth after withdrawal of 1,25(OH)2VD3. Overall, the study suggests that the down-regulation of telomerase activity by 1,25(OH)2VD3 and the resulting cell death are important components of the response of OCa cells to 1,25(OH)2VD3-induced growth suppression. Vitamin D is a lipophilic hormone, and its effects are mediated by the vitamin D receptor (VDR) 1The abbreviations used are: VDR, vitamin D (VD) receptor; RXR, retinoid X receptor; VDRE, vitamin D response element; OCa cells, ovarian epithelial cancer cells; hTERT, human telomerase reverse transcriptase; 1,25(OH)2VD3, 1,25-dihydroxyvitamin D3; EMSA, electrophoresis mobility shift assay; ChIP, chromatin immunoprecipitation; MTT, methylthiazole tetrazolium; TRAT, telomere repeat amplification; RT, reverse transcription; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; kb, kilobase(s).1The abbreviations used are: VDR, vitamin D (VD) receptor; RXR, retinoid X receptor; VDRE, vitamin D response element; OCa cells, ovarian epithelial cancer cells; hTERT, human telomerase reverse transcriptase; 1,25(OH)2VD3, 1,25-dihydroxyvitamin D3; EMSA, electrophoresis mobility shift assay; ChIP, chromatin immunoprecipitation; MTT, methylthiazole tetrazolium; TRAT, telomere repeat amplification; RT, reverse transcription; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; kb, kilobase(s). (1Baker A.R. McDonnell D.P. Hughes M. Crisp T.M. Mangelsdorf D.J. Haussler M.R. Pike J.W. Shine J. O'Malley B.W. Proc. Natl. Acad. Sci. U. S. A. 1988; 85: 3294-3298Crossref PubMed Scopus (859) Google Scholar), which is a member of the steroid/thyroid nuclear receptor superfamily. This super-family includes receptors for steroids such as progesterone, androgens, estrogens, glucocorticoids and mineralocorticoids, receptors for non-steroid hormones like vitamin D, thyroid hormones, all-trans-retinoic acid, and 9-cis-retinoic acid as well as orphan receptors for which the ligand is unknown. The VDR acts as a ligand-inducible transcription factor that in most cases forms heterodimers with the retinoid X receptor (RXR). The activated receptors bind vitamin D response elements (VDREs) to regulate the expression of the target genes through activation or repression of transcription. In addition to classic effects on calcium homeostasis, bone density, and mineral metabolism, the active metabolite of vitamin D, 1,25(OH)2VD3, modulates cellular proliferation (2Feldman D. Skowronski R.J. Peehl D.M. Adv. Exp. Med. Biol. 1995; 375: 53-63Crossref PubMed Scopus (79) Google Scholar, 3Blutt S.E. Allegretto E.A. Pike J.W. Weigel N.L. Endocrinology. 1997; 138: 1491-1497Crossref PubMed Scopus (191) Google Scholar), differentiation (4Takahashi T. Nakamura K. Iho S. Leuk. Lymphoma. 1997; 27: 25-33Crossref PubMed Scopus (16) Google Scholar), and apoptosis (5Welsh J. Biochem. Cell Biol. 1994; 72: 537-545Crossref PubMed Scopus (139) Google Scholar) of both normal and malignant cells. Our recent studies have shown that the growth of multiple OCa cell lines is suppressed by 1,25(OH)2VD3 (6Li P. Li C. Zhao X. Zhang X. Nicosia S.V. Bai W. J. Biol. Chem. 2004; 279: 25260-25267Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar), suggesting that active vitamin D compounds are potential therapeutic agents for OCa treatment and prevention. Molecular analyses have identified GADD45 as a primary target gene that mediates the effect of 1,25(OH)2VD3 on G2/M arrest (7Jiang F. Li P. Fornace Jr., A.J. Nicosia S.V. Bai W. J. Biol. Chem. 2003; 278: 48030-48040Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar) and the p27 CDK inhibitor as the mediator for the arrest at G1/S checkpoint (6Li P. Li C. Zhao X. Zhang X. Nicosia S.V. Bai W. J. Biol. Chem. 2004; 279: 25260-25267Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar). The ends of chromosomes, telomeres, are subject to progressive shortening in normal somatic cells, leading ultimately to irreversible growth arrest, known as senescence (8Kolquist K.A. Ellisen L.W. Counter C.M. Meyerson M. Tan L.K. Weinberg R.A. Haber D.A. Gerald W.L. Nat. Genet. 1998; 19: 182-186Crossref PubMed Scopus (362) Google Scholar). In contrast, the telomere length in cancer cells is stabilized by telomerase, an enzyme that catalyzes the synthesis of telomeric DNA repeats. Telomerase is a ribonucleoprotein complex containing three essential components, the telomerase RNA, which contains a sequence complementary to the telomeric TTAGGG repeat, the catalytic subunit, telomerase reverse transcriptase, which catalyzes the reverse transcription of TTAGGG repeats in the telomerase RNA, and the telomerase-associated protein 1, which helps the reverse transcription. Whereas all human somatic cells express the telomerase RNA constitutively (9Cech T.R. Cell. 2004; 116: 273-279Abstract Full Text Full Text PDF PubMed Scopus (352) Google Scholar, 10Newbold R.F. Mutagenesis. 2002; 17: 539-550Crossref PubMed Scopus (71) Google Scholar), the level of hTERT is increased in most human cancers, and its expression determines the cellular activity of telomerase (11Counter C.M. Hahn W.C. Wei W. Caddle S.D. Beijersbergen R.L. Lansdorp P.M. Sedivy J.M. Weinberg R.A. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 14723-14728Crossref PubMed Scopus (559) Google Scholar). Thus, the expression of the hTERT gene appears to be the rate-limiting factor for telomerase activity in human cancer cells. The reactivation of telomerase has been shown to be one of the three events required to transform a normal human epithelial cell into a cancer cell (12Hahn W.C. Counter C.M. Lundberg A.S. Beijersbergen R.L. Brooks M.W. Weinberg R.A. Nature. 1999; 400: 464-468Crossref PubMed Scopus (1974) Google Scholar). An anti-apoptotic function of telomerase has been described in human fibroblasts and neuronal cells (13Ren J.G. Xia H.L. Tian Y.M. Just T. Cai G.P. Dai Y.R. FEBS Lett. 2001; 488: 133-138Crossref PubMed Scopus (70) Google Scholar, 14Gorbunova V. Seluanov A. Pereira-Smith O.M. J. Biol. Chem. 2002; 277: 38540-38549Abstract Full Text Full Text PDF PubMed Scopus (194) Google Scholar, 15Fu W. Killen M. Culmsee C. Dhar S. Pandita T.K. Mattson M.P. J. Mol. Neurosci. 2000; 14: 3-15Crossref PubMed Google Scholar). Studies in epidermoid tumor cells indicate that inhibition of telomerase in tumor cells, whose telomeres are already short, leads to chromosomal damage, which in turn triggers apoptotic cell death (16Zhang X. Mar V. Zhou W. Harrington L. Robinson M.O. Genes Dev. 1999; 13: 2388-2399Crossref PubMed Scopus (558) Google Scholar). Thus, telomerase activation is most likely a causal event for tumorigenesis instead of just a marker for neoplasia, making telomerase an attractive target for discovery of anticancer drugs. Similar to other cancer cells, there was a significant correlation of telomerase activity in OCa cells with the expression hTERT mRNA but not with the expression of the other two components of telomerase (17Park T.W. Riethdorf S. Riethdorf L. Loning T. Janicke F. Int. J. Cancer. 1999; 84: 426-431Crossref PubMed Scopus (61) Google Scholar, 18Kyo S. Kanaya T. Takakura M. Tanaka M. Yamashita A. Inoue H. Inoue M. Int. J. Cancer. 1999; 80: 804-809Crossref PubMed Scopus (103) Google Scholar). OCa cells containing wild type hTERT are highly tumorigenic, cells expressing hTERT to in (12Hahn W.C. Counter C.M. Lundberg A.S. Beijersbergen R.L. Brooks M.W. Weinberg R.A. Nature. 1999; 400: 464-468Crossref PubMed Scopus (1974) Google Scholar), hTERT as a potential target for drugs. The that 1,25(OH)2VD3 apoptosis in OCa cells, which the down-regulation of telomerase activity through of hTERT mRNA. studies show that the down-regulation of hTERT and apoptosis are to of OCa cell growth induced by 1,25(OH)2VD3 as well as to the effect of the on the of OCa cells to resume proliferation after H. S. Biol. 1998; Full Text Full Text PDF PubMed Scopus (859) Google Scholar), hTERT S. Takakura M. Kanaya T. W. K. A. Inoue M. 1999; Google Scholar), and (7Jiang F. Li P. Fornace Jr., A.J. Nicosia S.V. Bai W. J. Biol. Chem. 2003; 278: 48030-48040Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar) have been described 1,25(OH)2VD3 was human VDR human protein and was and by The sequence of the in for complementary for electrophoresis mobility shift is hTERT are used to indicate the in the and has been described in a study (7Jiang F. Li P. Fornace Jr., A.J. Nicosia S.V. Bai W. J. Biol. Chem. 2003; 278: 48030-48040Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar). The of for chromatin are and and cell cells or the hTERT clones at in and with 1,25(OH)2VD3 or as described P. Nicosia S.V. Bai W. J. Biol. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). was on a the cells by and with Cell with and for and to Cell cycle analyses as described (7Jiang F. Li P. Fornace Jr., A.J. Nicosia S.V. Bai W. J. Biol. Chem. 2003; 278: 48030-48040Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar). analysis was the was to be Telomerase activity was by the telomeric repeat the telomerase to the Telomerase activity was as at by a with a of in and a of of telomerase was in to a used to with of protein that of protein was for and for telomerase activity in cells. and with the of the of DNA in reverse and in The of hTERT and are in the reverse and The of hTERT the of and and the reverse is in The are as of hTERT and glyceraldehyde-3-phosphate expression by as described T.M. J. T.R. 1997; 277: PubMed Scopus Google Scholar). RNA was with to the hTERT and to a region present in all of was in and to electrophoresis in and with RNA was the RNA and with An RNA was by of RNA cells with or 1,25(OH)2VD3 for of the RNA to used in the analysis to the for gene. The cycle was by the and to an the the cycle of the hTERT and the was at two and and the the of the was in at and hTERT to the EMSA, and and as described (7Jiang F. Li P. Fornace Jr., A.J. Nicosia S.V. Bai W. J. Biol. Chem. 2003; 278: 48030-48040Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar). cells in in at the cells by the cells with 1,25(OH)2VD3 or in for and and as described H. Bai W. Mol. Cell. Biol. 2002; PubMed Scopus Google Scholar). of hTERT Stable and of the of the of clones expressing hTERT or cells with or with of The clones through with for a of and by length was a of DNA was with of and and on a and DNA was to a and with The was by the The telomere length was by the to a 1,25(OH)2VD3 of OCa and to after of studies have shown that the growth of multiple OCa cell lines is suppressed by 1,25(OH)2VD3 through cell cycle arrest at both G1/S (6Li P. Li C. Zhao X. Zhang X. Nicosia S.V. Bai W. J. Biol. Chem. 2004; 279: 25260-25267Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar) and G2/M (7Jiang F. Li P. Fornace Jr., A.J. Nicosia S.V. Bai W. J. Biol. Chem. 2003; 278: 48030-48040Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar) of the cell cycle arrest at the activity of the (6Li P. Li C. Zhao X. Zhang X. Nicosia S.V. Bai W. J. Biol. Chem. 2004; 279: 25260-25267Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar, F. Li P. Fornace Jr., A.J. Nicosia S.V. Bai W. J. Biol. Chem. 2003; 278: 48030-48040Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar), suggesting the of 1,25(OH)2VD3 apoptosis in OCa cells, cells with or 1,25(OH)2VD3 at for and cell apoptosis was by after with V. shown in the 1, 1,25(OH)2VD3 increased the of apoptotic cells. The on in two that 1,25(OH)2VD3 increased the apoptotic of cells by more analysis that 1,25(OH)2VD3 not apoptosis the cells for a of not that apoptotic similar to G2/M arrest (7Jiang F. Li P. Fornace Jr., A.J. Nicosia S.V. Bai W. J. Biol. Chem. 2003; 278: 48030-48040Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar), is a analyses that the growth by 1,25(OH)2VD3 is likely due to the effect of the on both cell cycle progression and cell 1,25(OH)2VD3 a effect on the growth potential OCa cells, cells with the or the for of and and their to in the of 1,25(OH)2VD3 was in shown in 1, the of cells to was as the of with 1,25(OH)2VD3 for or for more the of the cells to after 1,25(OH)2VD3 that 1,25(OH)2VD3 a effect in OCa cells. the of to with is likely that these two are 1,25(OH)2VD3 Telomerase and the of hTERT mRNA in OCa an anti-apoptotic function of telomerase has been described for other cells and the cells apoptosis are with telomerase activity Lett. 2003; PubMed Scopus Google Scholar), we the that 1,25(OH)2VD3 apoptosis in OCa cells by down-regulating telomerase. 1,25(OH)2VD3 decreases telomerase, cells with 1,25(OH)2VD3, and the telomerase activity was by the telomeric repeat shown in cells a level of telomerase activity that was by 1,25(OH)2VD3 treatment in a The activity was to of the after of of the activity was in cells for and telomerase down-regulation the apoptotic the are with the that telomerase activity be for the cell death induced by the the level of hTERT is rate-limiting for the telomerase activity in cancer cells and the VDR is a transcription is that the telomerase activity is due to the down-regulation of the hTERT transcription by 1,25(OH)2VD3. the level of hTERT mRNA in cells with or 1,25(OH)2VD3 was by with 1,25(OH)2VD3 at the level of hTERT mRNA in a The decrease after of treatment and significant after treatment for or which to the decrease in telomerase activity The level of mRNA was not the for hTERT mRNA. the degree of the decrease in hTERT mRNA, was RNA cells with or 1,25(OH)2VD3. shown in hTERT mRNA was by after treatment for and to after The down-regulation of hTERT mRNA in the of an inhibitor of protein synthesis that the down-regulation not protein Thus, hTERT a primary target by 1,25(OH)2VD3 in OCa cells. The in the hTERT in OCa recent study the of a putative in the 5′ regulatory region of the hTERT H. H. M. M. S. K. Mol. 2003; Google Scholar). This element mediated the down-regulation of hTERT in cancer cells by 1,25(OH)2VD3 in with 9-cis-retinoic acid but not by 1,25(OH)2VD3 the that the down-regulation of hTERT mRNA by 1,25(OH)2VD3 in OCa cells is mediated through putative VDRE, the in of VDR and to such a response element was in shown in the putative of hTERT in The is for the VDR a complex with the The complex was by of human gene but not by a DNA element as shown in studies (7Jiang F. Li P. Fornace Jr., A.J. Nicosia S.V. Bai W. J. Biol. Chem. 2003; 278: 48030-48040Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar). The complex was by the addition of an but not by an that the is for the the mediates the down-regulation of hTERT expression in OCa cells, cells with a gene containing a 5′ regulatory region of hTERT including the putative H. H. M. M. S. K. Mol. 2003; Google Scholar) and with or 1,25(OH)2VD3. to 1,25(OH)2VD3 increased the activity of the the of repression was an of the the was stably into cells. Similar to the 1,25(OH)2VD3 not decrease the activity in the clones after treatment for The and the analyses as to the putative with the VDR in with chromatin cells with or 1,25(OH)2VD3. shown in D, in response to 1,25(OH)2VD3, the the GADD45 region containing the (7Jiang F. Li P. Fornace Jr., A.J. Nicosia S.V. Bai W. J. Biol. Chem. 2003; 278: 48030-48040Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar). not the hTERT containing the putative VDRE, that the VDR is not by the to the putative of hTERT in these we that the putative in hTERT is not in response to 1,25(OH)2VD3 in cells, the in in 1,25(OH)2VD3 has been shown to the C. N.L. J.M. PubMed Scopus Google Scholar), which in turn telomerase through two in the hTERT C. M. A. J. Nat. Genet. 1999; PubMed Scopus Google Scholar), there is a that the repression of telomerase by 1,25(OH)2VD3 is mediated by is not likely the with the hTERT region containing the regulatory elements not to inhibition by 1,25(OH)2VD3 and Overall, the that the hTERT mRNA is not due to transcriptional repression through the putative or the 1,25(OH)2VD3 the of hTERT the putative is not in OCa cells, the down-regulation of hTERT mRNA be due to increased of the mRNA. 1,25(OH)2VD3 the stability of hTERT mRNA, analyses in the of the RNA synthesis inhibitor D. by two of and by GAPDH, the level of hTERT mRNA more in the cells with 1,25(OH)2VD3 in cells In to cells, 1,25(OH)2VD3 the of hTERT mRNA to and to as with to the 5′ and the ends of the hTERT mRNA, Similar with two of RNA in two analyses show that the decrease in the level of hTERT mRNA induced by 1,25(OH)2VD3 is due at in to a decrease in mRNA Stable of hTERT in OCa Telomerase and 1,25(OH)2VD3-induced Cell the of the down-regulation of telomerase to the of hTERT is the factor for telomerase a hTERT expression H. S. Biol. 1998; Full Text Full Text PDF PubMed Scopus (859) Google Scholar) was stably into cells to telomerase shown in telomerase activity in cells stably expressing hTERT was the activity in parental cells. with studies M. P. F. Int. J. 2000; Google Scholar, C. M. M. 2001; Google Scholar), the telomere length was in cells but was more in clones analyses show that the expression of hTERT in cells telomerase activity and telomere The was 1,25(OH)2VD3 decreases telomerase activity and telomere shown in and D, telomerase activity telomere length in clones was by treatment with 1,25(OH)2VD3 for or as with telomere length in cells is already and is likely the length required for the shortening of telomere length not be due to apoptotic death of the cells induced by 1,25(OH)2VD3. The analyses that the expression of hTERT the effect of the 1,25(OH)2VD3 on telomerase activity in the clones and that hTERT was the rate-limiting factor for telomerase Thus, these clones by to of hTERT the cells 1,25(OH)2VD3-induced shown in in contrast to the in the apoptotic induced in parental cells after treatment with 1,25(OH)2VD3, hTERT clones apoptotic by the In two the apoptotic of the parental cells was increased to on In contrast, the apoptotic of the two clones was increased to on the two This shows that the expression of hTERT at cells 1,25(OH)2VD3-induced cell In contrast to the cell cycle arrest at G1/S and G2/M was induced to a similar degree in the parental cells and the hTERT as by these analyses that hTERT down-regulation is in the 1,25(OH)2VD3-induced apoptosis but not in the 1,25(OH)2VD3-induced cell cycle The effect on apoptosis was similar in two that is not due to the potential of the with Stable of hTERT 1,25(OH)2VD3-induced and OCa Cell to after analyses have shown that the expression of hTERT 1,25(OH)2VD3-induced apoptosis but not cell cycle Thus, these clones to down-regulation of hTERT with the apoptosis to the growth of OCa cells by 1,25(OH)2VD3. shown in the growth of the parental cells and the hTERT was inhibited by 1,25(OH)2VD3. the degree of inhibition in hTERT-expressing clones was that of the parental cells after of In the growth of parental cells after of treatment, the cells of clones continued in the of 1,25(OH)2VD3. a growth cells their to after the of 1,25(OH)2VD3 been for This suggests that 1,25(OH)2VD3 a effect on the growth of the cells. apoptosis is a that irreversible after cells is that the down-regulation of hTERT and the apoptosis to we the of the cells of expressing hTERT to after 1,25(OH)2VD3 withdrawal to that of parental cells. the treatment with 1,25(OH)2VD3 for the cells in with the and for in the of the shown in with 1,25(OH)2VD3 the of cells to the cells with the This is with the shown in In contrast, the growth after the with 1,25(OH)2VD3 of the two hTERT clones was not the cells with growth was similar to that of parental cells Our analysis suggests that down-regulation of telomerase in OCa cells and the resulting apoptosis to both the growth by the as well as its effect on after shortening of telomere with cell the of normal cells and leads to human cancers including OCa are with activation of that telomere of cancers show reactivation of telomerase. The present study shows that telomerase in OCa cells is by 1,25(OH)2VD3. of telomerase is due to stability of hTERT mRNA transcriptional repression through the putative present in the regulatory region of the hTERT gene H. H. M. M. S. K. Mol. 2003; Google Scholar). for RNA such as in mRNA and in cells has been in recent M.W. D.P. Cell. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar). the down-regulation of hTERT mRNA not protein is that the effect of 1,25(OH)2VD3 on hTERT be mediated through a RNA an protein that hTERT mRNA and its stability be by 1,25(OH)2VD3. the present study is the that the stability of hTERT mRNA is by a increased telomerase activity in cancer cells be due to an increased of hTERT transcription and 1,25(OH)2VD3 its effect at a the be to telomerase activity in cancer cells and to is important to that the down-regulation of hTERT by 1,25(OH)2VD3 is in cancer cells not suggesting that the effect of the 1,25(OH)2VD3 on hTERT is not to 1,25(OH)2VD3 has been shown to apoptosis in human cancer cells, but is known the Our study is the to the down-regulation of hTERT to 1,25(OH)2VD3-induced apoptosis in cancer cells. The studies with that the decrease in hTERT mRNA the of apoptosis by 1,25(OH)2VD3, suggesting that down-regulation is likely the and not the of 1,25(OH)2VD3-induced apoptosis in OCa cells. This is by the apoptotic response of the cells expressing hTERT to 1,25(OH)2VD3 and their increased to after withdrawal of of telomerase activity has been to cell senescence or senescence are with a express and show a arrest, cells are with apoptosis A. S. A. J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar). in study the of hTERT suppressed the of apoptosis by 1,25(OH)2VD3 an effect on the cell cycle arrest, the down-regulation of hTERT by 1,25(OH)2VD3 appears to OCa cells into a instead of This is by that the activity of the senescence is not induced by 1,25(OH)2VD3 in OCa cells not has been that the inhibitor of telomerase senescence K. U. P. H. C. C. M. C. J. A. J. 2001; PubMed Scopus (352) Google Scholar), the of hTERT apoptosis (16Zhang X. Mar V. Zhou W. Harrington L. Robinson M.O. Genes Dev. 1999; 13: 2388-2399Crossref PubMed Scopus (558) Google Scholar, W.C. Brooks M.W. A. Beijersbergen R.L. Meyerson M. Weinberg R.A. Nat. Med. 1999; PubMed Scopus Google Scholar), suggesting that the in which telomerase is inhibited the is that with the telomerase protein complex on the chromosomal instead of a inhibition of the catalytic activity of telomerase to the apoptotic is likely that the decrease in hTERT level in OCa cells with 1,25(OH)2VD3 the of of telomerase complex on chromosomal which more the with the hTERT the telomerase is known that the inhibition of telomerase to a which cells to the at which the telomeres This the apoptotic by 1,25(OH)2VD3 the treatment for more in the shortening of telomeric repeats was in parental cells after of treatment with 1,25(OH)2VD3 This is likely due to the that the telomere in cells is to the length required for and that cells with telomere have been has been shown that human cells the of the telomere a length of This is to ends and leads to the and cell death (11Counter C.M. Hahn W.C. Wei W. Caddle S.D. Beijersbergen R.L. Lansdorp P.M. Sedivy J.M. Weinberg R.A. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 14723-14728Crossref PubMed Scopus (559) Google Scholar). a decrease in telomere length was not study the that down-regulation of telomerase by 1,25(OH)2VD3 OCa cell apoptosis through of telomere or through a of its effect on for hTERT expression and for hTERT for the The cell cycle was in the and DNA in the Molecular at H. and
27
Prediction of Mammalian MicroRNA Targets
Benjamin P. Lewis, I‐hung Shih, Matthew W. Jones-Rhoades et al. · Cell · 2003 · 5.2K citations · Full text
Creation of human tumour cells with defined genetic elements
William C. Hahn, Christopher M. Counter, Ante S. Lundberg et al. · Nature · 1999 · 2.3K citations
Medicine, Cancer Biology, Genetics +13
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Toru Nakamura, Gregg B. Morin, Karen Chapman et al. · Science · 1997 · 2.3K citations · Full text
Inhibition of telomerase limits the growth of human cancer cells
William C. Hahn, Sheila A. Stewart, Mary W. Brooks et al. · Nature Medicine · 1999 · 1K citations
Medicine, Cell Biology, Oncology +12